The central role of interleukin-23/interleukin-17 (IL-23/IL-17) axis in the pathogenesis of psoriasis and the effectiveness of its targeted therapy have been confirmed by numerous studies [6, 7]. The gene discussed is IL23A; the disease is psoriasis.